A novel <it>Bifidobacterium infantis</it>-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer

<p>Abstract</p> <p>Bladder cancer is the ninth most common malignancy in the world. Successful clinical management remains a challenge. In order To search for novel targeted and efficacious treatment, we sought to investigate anti-tumor activity of BI-TK suicide gene therapy system...

Full description

Bibliographic Details
Main Authors: Ma Yongping, Zhou Shengcai, He Yunfeng, Tang Wei, Liu Geli
Format: Article
Language:English
Published: BMC 2009-12-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/28/1/155
id doaj-55224dd7a0ce4cabb1ac00c4dd0f9aec
record_format Article
spelling doaj-55224dd7a0ce4cabb1ac00c4dd0f9aec2020-11-24T23:57:15ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662009-12-0128115510.1186/1756-9966-28-155A novel <it>Bifidobacterium infantis</it>-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancerMa YongpingZhou ShengcaiHe YunfengTang WeiLiu Geli<p>Abstract</p> <p>Bladder cancer is the ninth most common malignancy in the world. Successful clinical management remains a challenge. In order To search for novel targeted and efficacious treatment, we sought to investigate anti-tumor activity of BI-TK suicide gene therapy system in a rat model of bladder tumors. We first constructed and tested an anaerobic Bifidobacterium infantis-mediated thymidine kinase (BI-TK) suicide gene therapy system. To test the in vivo efficacy of this system, we established a rat model of bladder tumors, which was induced by N-methyl-nitrosourea perfusion. Bifidobacterium infantis containing the HSV-TK (i.e., BI-TK) were constructed by transformation of recombinant plasmid pGEX - TK. The engineered BI-TK was injected into tumor-bearing rats via tail vein, followed by intraperitoneal injection of ganciclovir (GCV). Using the rat model of bladder tumors, we found that bladder tumor burdens were significantly lower in the rats treated with BI-TK/GCV group than that treated with normal saline control group (<it>p </it><<it>0.05</it>). While various degrees of apoptosis of the tumor cells were detected in all groups using in situ TUNEL assay, apoptosis was mostly notable in the BI-TK/GCV treatment group. Immunohistochemical staining further demonstrated that the BI-TK/GCV treatment group had the highest level of caspase3 protein expression than that of the empty plasmid group and normal saline group (p < 0.05). Thus, our results demonstrate that the Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system can effectively inhibit rat bladder tumor growth, possibly through increasing caspase 3 expression and inducing apoptosis.</p> http://www.jeccr.com/content/28/1/155
collection DOAJ
language English
format Article
sources DOAJ
author Ma Yongping
Zhou Shengcai
He Yunfeng
Tang Wei
Liu Geli
spellingShingle Ma Yongping
Zhou Shengcai
He Yunfeng
Tang Wei
Liu Geli
A novel <it>Bifidobacterium infantis</it>-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
Journal of Experimental & Clinical Cancer Research
author_facet Ma Yongping
Zhou Shengcai
He Yunfeng
Tang Wei
Liu Geli
author_sort Ma Yongping
title A novel <it>Bifidobacterium infantis</it>-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
title_short A novel <it>Bifidobacterium infantis</it>-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
title_full A novel <it>Bifidobacterium infantis</it>-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
title_fullStr A novel <it>Bifidobacterium infantis</it>-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
title_full_unstemmed A novel <it>Bifidobacterium infantis</it>-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
title_sort novel <it>bifidobacterium infantis</it>-mediated tk/gcv suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
publisher BMC
series Journal of Experimental & Clinical Cancer Research
issn 1756-9966
publishDate 2009-12-01
description <p>Abstract</p> <p>Bladder cancer is the ninth most common malignancy in the world. Successful clinical management remains a challenge. In order To search for novel targeted and efficacious treatment, we sought to investigate anti-tumor activity of BI-TK suicide gene therapy system in a rat model of bladder tumors. We first constructed and tested an anaerobic Bifidobacterium infantis-mediated thymidine kinase (BI-TK) suicide gene therapy system. To test the in vivo efficacy of this system, we established a rat model of bladder tumors, which was induced by N-methyl-nitrosourea perfusion. Bifidobacterium infantis containing the HSV-TK (i.e., BI-TK) were constructed by transformation of recombinant plasmid pGEX - TK. The engineered BI-TK was injected into tumor-bearing rats via tail vein, followed by intraperitoneal injection of ganciclovir (GCV). Using the rat model of bladder tumors, we found that bladder tumor burdens were significantly lower in the rats treated with BI-TK/GCV group than that treated with normal saline control group (<it>p </it><<it>0.05</it>). While various degrees of apoptosis of the tumor cells were detected in all groups using in situ TUNEL assay, apoptosis was mostly notable in the BI-TK/GCV treatment group. Immunohistochemical staining further demonstrated that the BI-TK/GCV treatment group had the highest level of caspase3 protein expression than that of the empty plasmid group and normal saline group (p < 0.05). Thus, our results demonstrate that the Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system can effectively inhibit rat bladder tumor growth, possibly through increasing caspase 3 expression and inducing apoptosis.</p>
url http://www.jeccr.com/content/28/1/155
work_keys_str_mv AT mayongping anovelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
AT zhoushengcai anovelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
AT heyunfeng anovelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
AT tangwei anovelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
AT liugeli anovelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
AT mayongping novelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
AT zhoushengcai novelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
AT heyunfeng novelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
AT tangwei novelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
AT liugeli novelitbifidobacteriuminfantisitmediatedtkgcvsuicidegenetherapysystemexhibitsantitumoractivityinaratmodelofbladdercancer
_version_ 1725454837806530560